Revolutionary One-Time Gene Therapy Offers Hope to Children Battling Life-Threatening Immune Disorders
Image Credit: dolgachov/123rf.com A groundbreaking gene therapy has demonstrated a 100% survival rate for children suffering from adenosine deaminase-severe combined immunodeficiency (ADA-SCID), a rare genetic disorder that compromises the immune system and can be fatal. The treatment, detailed in a recent study published in *The New England Journal of Medicine*, has successfully saved the lives…